5 products found
Acorda Therapeutics, Inc. Products
-
Products & Research
Therapies developed on a foundation of experience. We have a deep understanding of - and experience in - nervous system research, product development and commercialization. This expertise enables us to focus on therapies that have a potential to improve the lives of people with neurological disorders. In this section you can learn more about our pipeline programs as well as our approved products.
-
AMPYRA - Dalfampridine Extended Release Tablets, 10 mg
AMPYRA® (dalfampridine) Extended Release Tablets, 10 mg is a prescription medicine approved by the U.S. Food and Drug Administration (FDA) to help improve walking in adults with multiple sclerosis MS. This was demonstrated by an increase in walking ...
INBRIJA - Levodopa Inhalation Powder
INBRIJA is a prescription medicine used when needed for OFF episodes in adults with Parkinson’s treated with regular carbidopa/levodopa medicine. INBRIJA does not replace regular carbidopa/levodopa ...
Product Pipeline
Model rHlgM22 - Remyelinating Antibody
rHIgM22 is a remyelinating antibody that has been studied for the treatment of multiple sclerosis (MS). MS is a chronic, usually progressive disease in which a person’s own immune system attacks and degrades the function of nerve fibers in the brain and spinal cord by destroying myelin (a process known as demyelination) and eventually the nerve fibers ...
Model GGF2 - Cimaglermin Alfa
GGF2 is a member of the neuregulin growth factor family, and has been shown to promote recovery after neurological injury, as well as to enhance heart function in animal models of heart failure. GGF2 showed positive effects on cardiac function in the two Phase 1 clinical studies conducted to date. The Phase 1b trial assessed three doses of cimaglermin alfa in people with heart failure, but discontinued ...
ARCUS Technology
ARCUS - Innovative Technology Platform for Inhaled Medicines
ARCUS® is an innovative technology platform that transforms medicines into light, dry powders. These powders are designed to deliver high doses of medication through an inhalation device that is activated by a patient’s own ...